Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-28

Study Completion Date

2017-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries

NCT01856894

Polycystic Ovary Syndrome

COMPLETED

Advanced Glycation End Products and Dietary Intervention in Polycystic Ovary Patients

NCT05830487

Polycystic Ovary Syndrome Diet Habit

UNKNOWN NA

Ovarian Reserve and Matrix Metalloproteinases

NCT05443282

Oxidative Stress Ovarian Insufficiency, Primary Ovarian Failure, Premature

COMPLETED

The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)

NCT01475019

Obesity Polycystic Ovaries Syndrome

UNKNOWN PHASE4

Epicardial Adipose Tissue Thickness in Polycystic Ovary Syndrome (PCOS)

NCT01258946

Epicardial Adipose Tissue Pcos

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Materials and Methods: This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (\<25 kg/m2 and ≥25 kg/m2).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polycystic Ovary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Polycyctic ovary sendrome (PCOS)

these women who have PCOS, we will use their blood samples

preptin and amylin level

Intervention Type DIAGNOSTIC_TEST

we will take both of group blood samples to compare them serum preptin and amylin

Healty groups

These women who have reguler menstrual cycle, no akne or hirsutism, we will use their boold samples

preptin and amylin level

Intervention Type DIAGNOSTIC_TEST

we will take both of group blood samples to compare them serum preptin and amylin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

preptin and amylin level

we will take both of group blood samples to compare them serum preptin and amylin

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

the patients with PCOS

Exclusion Criteria

Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol

\-

Minimum Eligible Age

17 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes